CRT Capital Starts Ultragenyx Pharma (RARE) at Buy
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $15.20 -2.63%
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
CRT Capital initiated coverage on Ultragenyx Pharma (NASDAQ: RARE) with a Buy rating and a price target of $90.00.
For an analyst ratings summary and ratings history on Ultragenyx Pharma click here. For more ratings news on Ultragenyx Pharma click here.
Shares of Ultragenyx Pharma closed at $59.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
- New Street Research Starts MercadoLibre (MELI) at Buy
- Citi raises Ultragenyx Pharma price target to $32
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
